Logo
G

GEDEON RIKHTER-RUS, AO

Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 50 countries. Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange. The company sells products for the central nervous system, womens health and cardiovascular therapeutic areas among others. Richter is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter (18721944), a pharmacist, in 1901.
Country/AreaRussia
Company Emailoffice@gedeonrichter.com.pl
IndustrySports & EntertainmentHealthcarePersonal Care & Household CleaningPackaging & PrintingPharmaceuticals
Company website
Company phone+36 14314888
Established1901
Company Revenue$1,604,928,000
Number of employees12262
SIC Code28283
NAICS Code32325
Main ProductsEmployee recognitionEthics and complianceGedeon Richter Annual Report 2023 (non-official)Board of Directors and Supervisory BoardIUPAC-Richter Prize in Medicinal ChemistryClinical trialsRichter Health CityDrug safetyStock exchange announcementsEarnings presentation Q1 2024Richter for EducationResponsible marketingRichter GroupClimate changeUterine fibroidsVaginal infectionsGedeon Richter Annual Report 2023 - iXBRL packRichter for Women
http://www.linkedin.com/company/richter-gedeon-hungaryhttp://www.twitter.com/sabrina_richterhttps://www.facebook.com/policies/cookies

Company News

European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis
BUDAPEST, Hungary and BASEL, Switzerland and CAMBRIDGE, Mass , Nov. 2, 2023 /PRNewswire/ -- Gedeon Richter Plc. ('Richter') together with Sumitomo Pharma America, Inc. ('SMPA') and Sumitomo Pharma Switzerland, GmbH ('SMPS') today announce that the European Commission ('EC') has granted...
Gedeon Richter: an effective treatment for female schizophrenia patients
BUDAPEST, Hungary, Oct. 18, 2023 /PRNewswire/ -- Between the 7-10th of October 2023, during the 36th Annual Meeting of the European College of Neuropsychopharmacology (ECNP), new analyses of cariprazine studies were presented by Gedeon Richter Plc. Cariprazine was found to be effective in...
dateOct 18, 2023
Gedeon Richter: A new hope for treatment-resistant schizophrenia?
BUDAPEST, Hungary, Oct. 5, 2023 /PRNewswire/ -- At the 23rd World Congress of Psychiatry, organized between 28 September – 1 October 2023 in Vienna, new analyses of cariprazine studies were presented by Gedeon Richter Plc. The posters provided evidence about the safety profile of...
Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO® for Treatment of Endometriosis
BUDAPEST, Hungary and BASEL, Switzerland and CAMBRIDGE, Mass., Sept. 15, 2023 /PRNewswire/ -- Gedeon Richter Plc. ('Richter') together with Sumitomo Pharma America, Inc. ('SMPA') and Sumitomo Pharma Switzerland GmbH ('SMPS') today announce that the Committee for Medicinal Products for...
dateSep 15, 2023
Gedeon Richter: Cariprazine demonstrates broad-spectrum antidepressant effects across different patient populations
BUDAPEST, Hungary, March 29, 2023 /PRNewswire/ -- At the 31st Annual Meeting of the European Psychiatric Association (EPA), held between 25-28 March 2023 in Paris, France, new analyses of cariprazine studies were presented by Gedeon Richter Plc. The posters provided evidence for the...
dateMar 29, 2023

Web Summary

Q1: What is the address of Gedeon Richter's headquarters?
A1: The company is headquartered in Hungary.

Q2: What year was Gedeon Richter founded?
A2: Gedeon Richter Plc. was founded in 1901.

Q3: What is the main industry of Gedeon Richter?
A3: The company operates as a specialty pharmaceutical company, focusing on innovation-driven research and development.

Q4: What are some areas of expertise for Gedeon Richter?
A4: The company aims to offer high-added value products in original research, women's healthcare, and biosimilars.

Q5: Who is the current CEO of Gedeon Richter?
A5: As of November 1, 2017, Gábor Orbán has been serving as the Chief Executive Officer (CEO) of the company.

Q6: What is the number of employees in Gedeon Richter's R&D base?
A6: The company's R&D base employs more than 1,200 people, making it the most important pharmaceutical research centre in Central Eastern Europe.

Q7: What types of products does Gedeon Richter manufacture?
A7: The company manufactures over 200 drugs, including original, generic, and licensed products, focusing on central nervous system, cardiovascular, and gynaecological products.

Q8: Who is the HR and Technical Director at Gedeon Richter?
A8: Katalin Erdei has been serving as the HR and Technical Director since joining the company in 2018, with over 18 years of experience in human resource management.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png